Loading
Research Solutions, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 23 Jun 2022.
Research Solutions, Inc.: what insiders have been doing
Research Solutions, Inc. belongs to the Business Services sector. Filings by its managers are published through SEC (Form 4). Over the twelve months to 18 October 2026, 4 filings were filed, from 4 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Over the last twelve months, not one insider purchase of Research Solutions, Inc. stock was filed. Typically, a trade is published a median of 8 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction.
With 4 filings in twelve months, the company is quieter than the median of 19 filings across the 5,816 companies we follow on the same exchange. Over the whole record (from 2016), the tally stands at 2 purchases and 19 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 30 June 2026), the company reported revenue of 48.3 m USD and net income of 2.8 m USD.
In the same sector, recent insider purchases at Coursera, Inc. also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
149
Thresholds
n/a
Buy Volume
€9,330
2 ops. · all time
Sell Volume
€2M
19 ops. · all time
Since the insiders bought
- +16.9%Entry US$1.77 · Close at T+365 US$2.07
- -2.7%Entry US$2.20 · Close at T+365 US$2.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,097 of 24,148 companies
61.9
score / 100
Value54
Quality70
FCF yld7.8%
Earn yld4.2%
EV/EBITDA17.5x
ROE16%
Gross mgn52%
Net mgn5.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
US$1.96
Analyst consensus
3 analysts1.33/5
US$3.50Target US$3.83(+96%)US$4.00
Income statement
RevenueUS$48.3M
Gross profitUS$25.1M52% margin
EBITDAUS$3.9M8% margin
Net incomeUS$2.8M5.8% margin
Valuation
PER (trailing)21.8x
PER (forward)11.2x
P/Book3.1x
Beta0.77
Balance sheet & cash
Market capUS$66.2M
Free Cash FlowUS$5.2M
Profitability & ownership
ROE16.3%
ROA4.9%
% insiders13.8%
% institutions44.3%
Last declaration on 3 August 2026
Declarations149 total
284,000 shares@ US$2.200.86% mcap74.4% of flowCommon StockSEC:0001104659-26-089549:0
30,000 shares@ US$3.00100.0% of flowCommon StockSEC:0001104659-25-123916:0
75,000 shares@ US$0.7016.4% of flowCommon StockSEC:0001104659-25-120763:0
150,000 shares@ US$0.7063.5% of flowCommon StockSEC:0001104659-25-115046:0
2,225 shares@ US$3.662.6% of flowCommon StockSEC:0001104659-25-093873:0
1,428 shares@ US$3.661.6% of flowCommon StockSEC:0001104659-25-093872:0
2,126 shares@ US$2.691.8% of flowCommon StockSEC:0001104659-25-061854:0
933 shares@ US$2.690.5% of flowCommon StockSEC:0001104659-25-061855:0
2,909 shares@ US$2.692.5% of flowCommon StockSEC:0001104659-25-061853:0
75,000 shares@ US$1.1026.0% of flowCommon StockSEC:0001104659-25-060722:0
30,000 shares@ US$1.1020.2% of flowCommon StockSEC:0001104659-25-057462:0
50,000 shares@ US$1.0516.8% of flowCommon StockSEC:0001104659-25-056481:0
35,086 shares@ US$2.8512.6% of flowCommon StockSEC:0001104659-25-026735:0
41,688 shares@ US$2.8540.2% of flowCommon StockSEC:0001104659-25-026734:0
44,468 shares@ US$2.8542.4% of flowCommon StockSEC:0001104659-25-026737:0
21,980 shares@ US$2.8511.9% of flowCommon StockSEC:0001104659-25-026736:0
2,204 shares@ US$3.933.1% of flowCommon StockSEC:0001104659-24-131429:0
24,981 shares@ US$3.9313.0% of flowCommon StockSEC:0001104659-24-131428:0
919 shares@ US$3.930.7% of flowCommon StockSEC:0001104659-24-131427:0
1,986 shares@ US$3.932.7% of flowCommon StockSEC:0001104659-24-131431:0
340,000 shares0Common StockSEC:0002044787-24-000002:0
2,865 shares@ US$2.822.7% of flowCommon StockSEC:0001104659-24-102371:0
2,975 shares@ US$2.822.7% of flowCommon StockSEC:0001104659-24-102366:0
1,837 shares@ US$2.821.0% of flowCommon StockSEC:0001104659-24-102370:0
530 shares@ US$2.821.9% of flowCommon StockSEC:0001104659-24-102369:0
25 of 149 declarations
About Research Solutions, Inc.
Research Solutions, Inc. (ticker: RSSS) is a U.S.-listed company trading on NASDAQ in the United States. It operates as a specialized, vertical SaaS and managed-services provider focused on scientific, technical, and medical (STM) research workflows. For French-speaking investors in Europe, the key point is that RSSS is not a broad-based software vendor; it is a niche research-infrastructure company that sits inside the knowledge-management and scientific-content value chain. The company was incorporated in Nevada on November 2, 2006, following a share-exchange transaction with Reprints Desk, and later changed its name to Research Solutions, Inc. in 2013. It has operated as a fully remote company since 2019 and uses a Henderson, Nevada mailing address in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001386301/000110465925091644/rsss-20250630x10k.htm?utm_source=openai))
Its core business is helping researchers discover, access, acquire, and manage STM content more efficiently. The flagship platform family includes Article Galaxy and Article Galaxy Scholar, which help research organizations manage entitlements, subscriptions, token packages, and libraries of articles. In addition, the company offers discovery tools that search across nearly the full universe of STM articles, with advanced capabilities that include Resolute.ai and Scite.ai. These tools extend beyond traditional article search by surfacing related datasets such as clinical trials, patents, life-science and medtech regulatory information, competitive landscapes, and internal customer content. This integrated combination of content access and research intelligence is one of RSSS’s main competitive differentiators. ([stockanalysis.com](https://stockanalysis.com/stocks/rsss/company/?utm_source=openai))
Read moreShow less
Research Solutions serves corporate, academic, government, and individual researchers in the United States, Europe, and internationally. Its market position is best understood as a vertical research workflow platform competing in a fragmented ecosystem of content vendors, library workflow providers, and scientific intelligence solutions. The company’s value proposition centers on reducing research friction, improving compliance around content access, and lowering the total cost of scientific information retrieval. In other words, RSSS aims to make the research process faster and more efficient rather than simply selling content on a standalone basis. ([stockanalysis.com](https://stockanalysis.com/stocks/rsss/company/?utm_source=openai))
Recent operating updates suggest improving momentum. In fiscal third-quarter 2025, management said annual recurring revenue surpassed $20 million for the first time, with growth across both B2B and B2C recurring revenue streams. More recently, on May 14, 2026, the company reported fiscal third-quarter 2026 results showing improved profitability over the first nine months and highlighted the launch of two new AI-based products that allow Article Galaxy and Scite users to search, review, and acquire scientific literature within their existing AI tools. From an equity research perspective, that combination of product innovation and improving profitability is important because it suggests RSSS is gradually strengthening both its growth profile and operating leverage. ([researchsolutions.com](https://www.researchsolutions.com/resources/press-releases/research-solutions-reports-fiscal-third-quarter-2025-results?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
